Skip to Main Content

Paper Details

Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial.
Circulation
17
2019
Icosapent Ethyl
Author NameAffiliation
Xiaoming JiaBaylor College of Medicine
Julia M AkeroydMichael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development Center for Innovations
Khurram NasirCenter for Outcomes Research and Evaluation, Yale School of Medicine
Vijay NambiBaylor College of Medicine
Vijay NambiMichael E. DeBakey Veterans Affairs Medical Center
Vijay NambiCenter for Cardiovascular Disease Prevention
Christie M BallantyneBaylor College of Medicine
Christie M BallantyneCenter for Cardiovascular Disease Prevention
Christie M BallantyneBaylor College of Medicine
Christie M BallantyneCenter for Cardiovascular Disease Prevention
Laura A PetersenMichael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development Center for Innovations
Salim S ViraniBaylor College of Medicine
Salim S ViraniMichael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development Center for Innovations
Salim S ViraniMichael E. DeBakey Veterans Affairs Medical Center
Salim S ViraniCenter for Cardiovascular Disease Prevention
  • 1 - 15

Datasets

Release 1.2